Curative Biosciences, Inc.
Other OTCTotal Valuation
Curative Biosciences, Inc. carries a market capitalization of 25,789.00, placing it among publicly traded companies globally.
| Market Cap | 25,789.00 |
| Enterprise Value | N/A |
Share Statistics
Curative Biosciences, Inc. currently has 19.57M shares outstanding.
| Shares Outstanding | 19.57M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.00 |
| P/TBV Ratio | -0.05 |
| P/FCF Ratio | -0.46 |
| P/OCF Ratio | -0.46 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -6,150.23 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Curative Biosciences, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -515,487.00, while operating income came in at -518,095.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -518,095.00 |
| Pretax Income | -518,095.00 |
| Net Income | -518,095.00 |
| EBITDA | -515,487.00 |
| EBIT | -518,095.00 |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Total book value stands at -53.64M, with working capital of -718,558.00 providing operational flexibility.
| Cash & Cash Equivalents | 982.00 |
| Total Debt | N/A |
| Net Debt | 155,471.00 |
| Equity (Book Value) | -53.64M |
| Book Value Per Share | -3.13 |
| Working Capital | -718,558.00 |
Cash Flow
Curative Biosciences, Inc. produced -81,808.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -81,808.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -81,808.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -253.01 |
| FCF Yield | -217.17 |
Stock Splits
Curative Biosciences, Inc.'s most recent stock split took place on October 28, 2013 with a 100:1 split ratio.
| Last Split Date | 10/28/2013 |
| Split Ratio | 100:1 |
Scores
Curative Biosciences, Inc. posts an Altman Z-Score of -57,512.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -57,512.63 |